Clinical Trial Update: A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study in hypertensive children and adolescents evaluated the safety, tolerability, and pharmacokinetics of aliskiren; results were posted after study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-05-09